This funding opportunity enables rigorous clinical validation of strong candidate biomarkers for neurological or neuromuscular disorders. It supports studies that establish positive and negative predictive values of biomarkers within clinical populations, assuming prior identification and analytical validation of the biomarker and detection methods. The goal is to meet FDA guidelines for biomarker validation in relevant clinical contexts.
Eligible applicants include a wide range of U.S. entities such as city, county, and state governments, federally recognized tribal governments, nonprofits, for-profit organizations, small businesses, and institutions of higher education. Specific eligibility details should be confirmed with the fund
